Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Everolimus, Cetuximab and Capecitabine in Patients With Metastatic Pancreatic Cancer

This study has been completed.
Information provided by:
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Identifier:
First received: February 25, 2010
Last updated: May 19, 2014
Last verified: September 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2011
  Primary Completion Date: August 2010 (Final data collection date for primary outcome measure)